首页> 外文OA文献 >Radioimmunotherapy Combined with Maintenance Anti-CD20 Antibody May Trigger Long-Term Protective T Cell Immunity in Follicular Lymphoma Patients

【2h】

Radioimmunotherapy Combined with Maintenance Anti-CD20 Antibody May Trigger Long-Term Protective T Cell Immunity in Follicular Lymphoma Patients

机译：联合维持抗CD20抗体的放射免疫疗法可能会引发滤泡淋巴瘤患者的长期保护性T细胞免疫力

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Franz Buchegger; Steven M. Larson; Jean-Pierre Mach; Yves Chalandon; Pierre-Yves Dietrich; Anne Cairoli; John O. Prior; Pedro Romero; Daniel E. Speiser;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 复发性晚期滤泡性淋巴瘤的IDEC-C2B8(利妥希玛)抗CD20抗体治疗:德国低度恶性淋巴瘤研究组Ⅱ期研究结果 [J] . 李登举, 唐锦治中德临床肿瘤学杂志（英文版） . 2001,第004期
2. Radioimmunotherapy Combined with Maintenance Anti-CD20 Antibody May Trigger Long-Term Protective T Cell Immunity in Follicular Lymphoma Patients [J] . Franz Buchegger, Steven M. Larson, Jean-Pierre Mach, Clinical & developmental immunology. . 2013,第Pta4期

机译：放射免疫疗法与维持性抗CD20抗体联合可触发滤泡性淋巴瘤患者的长期保护性T细胞免疫
3. Radioimmunotherapy Combined with Maintenance Anti-CD20 Antibody May Trigger Long-Term Protective T Cell Immunity in Follicular Lymphoma Patients [J] . Franz Buchegger, Steven M. Larson, Jean-Pierre Mach, Clinical & developmental immunology. . 2013,第1期

机译：放射免疫疗法与维持性抗CD20抗体联合可触发滤泡性淋巴瘤患者的长期保护性T细胞免疫
4. Radioimmunotherapy Combined with Maintenance Anti-CD20 Antibody May Trigger Long-Term Protective T Cell Immunity in Follicular Lymphoma Patients [J] . FranzBuchegger, Steven M.Larson, Jean-PierreMach, Developmental Immunology: Journal of Immunology Research . 2013,第20期

机译：放射免疫疗法与维持性抗CD20抗体联合可触发滤泡性淋巴瘤患者的长期保护性T细胞免疫
5. Modeling Radioimmunotherapy with Anti-CD20 Antibody - Optimal Preload Depending on Lymphoma Transcapillary Solute Exchange [C] . P. Kletting, S.N. Reske, G. Glatting World congress on medical physics and biomedical engineering;International congress of the IUPESM . 2011

机译：用抗CD20抗体模拟放射免疫疗法-最佳预载取决于淋巴瘤经毛细血管溶质交换
6. Transfection of cells of low-grade lymphoproliferative disorders (chronic lymphocyte leukemia and follicular lymphoma) with myc and/or ras and mutantp53. [D] . Zheng, Changyu. 1996

机译：用myc和/或ras和突变体p53转染低度淋巴细胞增生性疾病（慢性淋巴细胞性白血病和滤泡性淋巴瘤）的细胞。
7. Radioimmunotherapy Combined with Maintenance Anti-CD20 Antibody May Trigger Long-Term Protective T Cell Immunity in Follicular Lymphoma Patients [O] . Franz Buchegger, Steven M. Larson, Jean-Pierre Mach, 2013

机译：放射免疫疗法与维持性抗CD20抗体联合可触发滤泡性淋巴瘤患者的长期保护性T细胞免疫
8. Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies? [O] . Buchegger, F., Mach, J.-P, Press, O. W., 2017

机译：通过基于抗CD20抗体的免疫疗法和放射免疫疗法相结合来提高滤泡性淋巴瘤治愈的机会？

Radioimmunotherapy Combined with Maintenance Anti-CD20 Antibody May Trigger Long-Term Protective T Cell Immunity in Follicular Lymphoma Patients

著录项

相似文献

相关主题

期刊订阅